CSF3 and type 1 diabetes mellitus: In this study, we sought to identify longitudinal trends in circulating amylase, lipase, and trypsin before and after treatment with anti-thymocyte globulin (ATG) and pegylated granulocyte colony-stimulating factor (GCSF) in patients with new-onset T1D.